Foamix focuses on topical foam products for the prescription, OTC and cosmetics markets. Its strategy is designed to maximize potential opportunities for its unique foam platforms: Foamix promotes global development by forming strategic alliances and corporate partnerships with leading pharmaceutical companies. Foamix will continue to enhance its R&D capabilities and expand its project line and develop additional forms and versions of the Foamix Foam and OILGEL(TM) platforms, suitable for all forms of actives. Foamix actively prosecute its intellectual property portfolio to protect its franchise and its current and future collaborative developments. Foamix utilizes its core technologies to develop products in-house which are available for licensing and also co-operates with leading pharmaceutical companies in the development of foam-based products for the delivery of proprietary actives.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Foamix Ltd
P.O. Box 4038
Weizmann-Science Park
2 Holzman Street
Ness Ziona
74140 Israel
All rights reserved. Terms and Conditions | Contact us
